‹ All Posts
Palak Jain

17th Aug · SEBI-Registered Analyst

Molbio
Diagnostics makes a strong D-Street debut, shares list with over 21% premium over IPO price - Check listing price, market cap

MOLBIO
made a strong stock market debut on Monday (August 17) at a premium of over 21 per cent, after the issue received a solid response in the primary market. Molbio Diagnostics shares opened at Rs 980 on the BSE, with a premium of Rs 173 or 21.44 per cent over the issue price of Rs 807. On the other hand, the stock opened at Rs 980 on the NSE, surging Rs 173 or 21.44 per cent from the IPO price.

#WatchOutFor#EquityResearch#IndexStrategies#TrendingSectors#SectorBreakouts
644 likes·66 comments